J.P. Marvel Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
6,824
+2,824
| +71% | +$921K | 0.36% | 44 |
|
|
2025
Q1 | $1.08M | Hold |
4,000
| – | – | 0.19% | 52 |
|
|
2024
Q4 | $941K | Hold |
4,000
| – | – | 0.16% | 56 |
|
|
2024
Q3 | $1.1M | Hold |
4,000
| – | – | 0.18% | 58 |
|
|
2024
Q2 | $972K | Hold |
4,000
| – | – | 0.16% | 59 |
|
|
2024
Q1 | $598K | Hold |
4,000
| – | – | 0.1% | 65 |
|
|
2023
Q4 | $766K | Hold |
4,000
| – | – | 0.15% | 60 |
|
|
2023
Q3 | $708K | Hold |
4,000
| – | – | 0.15% | 59 |
|
|
2023
Q2 | $760K | Hold |
4,000
| – | – | 0.16% | 57 |
|
|
2023
Q1 | $801K | Hold |
4,000
| – | – | 0.18% | 58 |
|
|
2022
Q4 | $951K | Sell |
4,000
-8
| -0.2% | -$1.9K | 0.22% | 56 |
|
|
2022
Q3 | $802K | Hold |
4,008
| – | – | 0.2% | 56 |
|
|
2022
Q2 | $585K | Hold |
4,008
| – | – | 0.14% | 61 |
|
|
2022
Q1 | $654K | Hold |
4,008
| – | – | 0.13% | 60 |
|
|
2021
Q4 | $680K | Buy |
+4,008
| New | +$680K | 0.13% | 58 |
|
|
2021
Q3 | – | Sell |
-2,000
| Closed | -$339K | – | 64 |
|
|
2021
Q2 | $339K | Sell |
2,000
-400
| -17% | -$67.8K | 0.07% | 67 |
|
|
2021
Q1 | $339K | Hold |
2,400
| – | – | 0.08% | 68 |
|
|
2020
Q4 | $312K | Sell |
2,400
-530
| -18% | -$68.9K | 0.08% | 65 |
|
|
2020
Q3 | $427K | Hold |
2,930
| – | – | 0.12% | 61 |
|
|
2020
Q2 | $434K | Hold |
2,930
| – | – | 0.14% | 58 |
|
|
2020
Q1 | $319K | Buy |
2,930
+930
| +47% | +$101K | 0.12% | 57 |
|
|
2019
Q4 | $230K | Buy |
+2,000
| New | +$230K | 0.07% | 68 |
|
|
2018
Q2 | – | Sell |
-2,000
| Closed | -$238K | – | 83 |
|
|
2018
Q1 | $238K | Hold |
2,000
| – | – | 0.07% | 77 |
|
|
2017
Q4 | $254K | Buy |
+2,000
| New | +$254K | 0.08% | 77 |
|
|
2017
Q1 | – | Sell |
-18,652
| Closed | -$698K | – | 85 |
|
|
2016
Q4 | $698K | Sell |
18,652
-36,725
| -66% | -$1.37M | 0.24% | 63 |
|
|
2016
Q3 | $3.75M | Buy |
55,377
+3,083
| +6% | +$209K | 1.33% | 34 |
|
|
2016
Q2 | $2.9M | Sell |
52,294
-178
| -0.3% | -$9.88K | 1.02% | 38 |
|
|
2016
Q1 | $3.29M | Buy |
52,472
+1,182
| +2% | +$74.2K | 1.19% | 35 |
|
|
2015
Q4 | $4.83M | Buy |
+51,290
| New | +$4.83M | 1.68% | 25 |
|
|
2015
Q2 | $6.16M | Sell |
51,370
-435
| -0.8% | -$52.1K | 2.07% | 19 |
|
|
2015
Q1 | $5.41M | Sell |
51,805
-800
| -2% | -$83.5K | 1.84% | 20 |
|
|
2014
Q4 | $5.1M | Sell |
52,605
-8,671
| -14% | -$841K | 1.77% | 20 |
|
|
2014
Q3 | $4.79M | Buy |
61,276
+7,021
| +13% | +$548K | 1.73% | 21 |
|
|
2014
Q2 | $3.43M | Buy |
54,255
+1,200
| +2% | +$75.8K | 1.17% | 39 |
|
|
2014
Q1 | $3.56M | Sell |
53,055
-1,100
| -2% | -$73.9K | 1.26% | 35 |
|
|
2013
Q4 | $3.48M | Buy |
54,155
+150
| +0.3% | +$9.65K | 1.25% | 37 |
|
|
2013
Q3 | $3.46M | Buy |
54,005
+4,000
| +8% | +$256K | 1.34% | 32 |
|
|
2013
Q2 | $1.55M | Buy |
+50,005
| New | +$1.55M | 0.65% | 52 |
|